By Rahul Koul
“ Our next big focus is the convergence of AI diagnostics, portable imaging & personalized screening”
In an exclusive interaction, Koji Wada, Managing Director, FUJIFILM India shared insights into the company’ s key growth drivers, technology trends, business growth and future outlook
BioTech
By Rahul Koul
Over the years, FUJIFILM has seen steady growth in imaging technologies. What is driving your year-on-year expansion in India’ s CT, MRI, and X-ray market?
Our growth in CT, MRI, and X-ray is powered by continuous innovation and a strong understanding of India’ s healthcare needs.
We focus on technologies that deliver precision, patient comfort, and clinical efficiency. With public and private healthcare expanding rapidly, we have aligned with this momentum through localized service, training, and application support.
We have strengthened our footprint through collaborations with leading hospitals, diagnostic chains, and government healthcare bodies, ensuring greater accessibility to our systems across regions. As the country shifts toward preventive screening, our solutions play a critical role in enabling early and accurate diagnosis, supporting national health priorities.
BIOVOICENEWS. COM 27